MC
PMD

Moors & Cabot’s Psychemedics Corporation PMD Stock Holding History

Moors & Cabot’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,541
Closed -$75K – 703
2020
Q1 		$75K Sell
12,541
-6,225
-33% -$52.4K 0.01% 553
2019
Q4 		$174K Sell
18,766
-825
-4% -$7.62K 0.02% 581
2019
Q3 		$182K Buy
19,591
+4,000
+26% +$34K 0.02% 557
2019
Q2 		$156K Buy
15,591
+66
+0.4% +$749 0.02% 522
2019
Q1 		$217K Sell
15,525
-22,407
-59% -$385K 0.03% 469
2018
Q4 		$605K Sell
37,932
-19,900
-34% -$343K 0.1% 224
2018
Q3 		$1.09M Sell
57,832
-320,425
-85% -$6.38M 0.13% 178
2018
Q2 		$7.28M Buy
378,257
+978
+0.3% +$19.8K 0.98% 18
2018
Q1 		$8.06M Buy
377,279
+3,983
+1% +$82.7K 1.07% 15
2017
Q4 		$7.67M Buy
373,296
+36,236
+11% +$672K 1.02% 14
2017
Q3 		$6.22M Buy
337,060
+19,763
+6% +$435K 0.9% 18
2017
Q2 		$7.91M Buy
317,297
+23,674
+8% +$498K 1.31% 10
2017
Q1 		$5.88M Sell
293,623
-68,270
-19% -$1.5M 0.99% 13
2016
Q4 		$8.93M Sell
361,893
-137,076
-27% -$3.07M 1.47% 9
2016
Q3 		$9.89M Buy
498,969
+19,902
+4% +$369K 1.65% 6
2016
Q2 		$6.57M Buy
479,067
+90,359
+23% +$1.26M 1.15% 11
2016
Q1 		$5.36M Buy
388,708
+189,168
+95% +$2.17M 0.97% 14
2015
Q4 		$2.01M Buy
199,540
+43,156
+28% +$470K 0.37% 70
2015
Q3 		$1.56M Buy
156,384
+58,010
+59% +$676K 0.29% 86
2015
Q2 		$1.45M Buy
98,374
+63,900
+185% +$995K 0.24% 107
2015
Q1 		$573K Sell
34,474
-1,445
-4% -$22.6K 0.1% 245
2014
Q4 		$549K Buy
35,919
+722
+2% +$10.5K 0.09% 246
2014
Q3 		$492K Sell
35,197
-1,099
-3% -$15.6K 0.08% 258
2014
Q2 		$509K Buy
36,296
+25,796
+246% +$392K 0.09% 259
2014
Q1 		$180K Buy
+10,500
New +$174K 0.05% 343

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Moors & Cabot's PMD Position: Q2 2020 in Review

Moors & Cabot sold out of Psychemedics Corporation (PMD) in Q2 2020, closing a stake of 12,541 shares — an estimated $75K sold.

Moors & Cabot first reported a position in PMD in Q1 2014 and held it in 25 quarters. The position peaked at $9.89M in Q3 2016. 35 funds tracked by Wall St. Rank hold PMD as of Q2 2020.

  • Moors & Cabot reported no remaining Psychemedics Corporation position as of Q2 2020 after selling out during the quarter.
  • Moors & Cabot sold 12,541 Psychemedics Corporation shares in Q2 2020, an estimated $75K.
  • Moors & Cabot first reported a position in Psychemedics Corporation in Q1 2014 and held it in 25 quarters.
  • Moors & Cabot's Psychemedics Corporation position peaked at $9.89M in Q3 2016.
  • 35 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2020.

Based on Moors & Cabot's 13F filing for Q2 2020, filed 13 Aug 2020.